tetano
Editor, Senior Moderator
Eur Rev Med Pharmacol Sci
. 2023 Dec;27(24):12141-12152.
doi: 10.26355/eurrev_202312_34812. Global cardiovascular risk, COVID-19 severity and post-COVID-19 syndrome: a clinical study
V Zaccone[SUP] 1 [/SUP], L Falsetti, L Santoro, E Guerrieri, S Santini, G Viticchi, M Tosato, M Danese, C Miro, S Cataldi, A Gasbarrini, F Landi, A Santoliquido, G Moroncini
Affiliations
Objective: Post-COVID-19 is a syndrome defined by signs and symptoms present until 12 weeks after COVID-19, lasting for more than 8 weeks, not explained by an alternative diagnosis. The present study aimed to assess whether the cardiovascular risk (CVR) of patients with COVID-19 correlates with symptoms and changes in respiratory function parameters in post-COVID-19. The association between CVR and the severity of acute disease was also considered.
Patients and methods: Between 21/04/21-01/09/21, we enrolled 1,782 consecutive patients with COVID-19. We divided these subjects into (i) 4 levels, based on the severity of COVID-19 (home care; hospitalized/no oxygen therapy; hospitalized/oxygen therapy; hospitalized/NIV-ICU), (ii) 2 levels, according to CVR calculated with the European Society of Cardiology SCORE tables (low-intermediate risk; high or very high risk). All subjects underwent a 3-month follow-up considering post-COVID-19 symptoms.
Results: In post-COVID-19 patients, high or very-high CVR was associated with (i) increased risk of hospitalization for COVID-19 (p<0.0001), (ii) higher prevalence of severe clinical manifestations and ICU admission (p<0.0001), (iii) development of post-COVID-19 (p<0.0001) and (iv) increased risk of a larger post-COVID-19 burden of disease.
Conclusions: We found a statistically significant association between CVR, severity of COVID-19, and post-COVID-19 syndrome three months after the end of acute disease.
. 2023 Dec;27(24):12141-12152.
doi: 10.26355/eurrev_202312_34812. Global cardiovascular risk, COVID-19 severity and post-COVID-19 syndrome: a clinical study
V Zaccone[SUP] 1 [/SUP], L Falsetti, L Santoro, E Guerrieri, S Santini, G Viticchi, M Tosato, M Danese, C Miro, S Cataldi, A Gasbarrini, F Landi, A Santoliquido, G Moroncini
Affiliations
- PMID: 38164876
- DOI: 10.26355/eurrev_202312_34812
Objective: Post-COVID-19 is a syndrome defined by signs and symptoms present until 12 weeks after COVID-19, lasting for more than 8 weeks, not explained by an alternative diagnosis. The present study aimed to assess whether the cardiovascular risk (CVR) of patients with COVID-19 correlates with symptoms and changes in respiratory function parameters in post-COVID-19. The association between CVR and the severity of acute disease was also considered.
Patients and methods: Between 21/04/21-01/09/21, we enrolled 1,782 consecutive patients with COVID-19. We divided these subjects into (i) 4 levels, based on the severity of COVID-19 (home care; hospitalized/no oxygen therapy; hospitalized/oxygen therapy; hospitalized/NIV-ICU), (ii) 2 levels, according to CVR calculated with the European Society of Cardiology SCORE tables (low-intermediate risk; high or very high risk). All subjects underwent a 3-month follow-up considering post-COVID-19 symptoms.
Results: In post-COVID-19 patients, high or very-high CVR was associated with (i) increased risk of hospitalization for COVID-19 (p<0.0001), (ii) higher prevalence of severe clinical manifestations and ICU admission (p<0.0001), (iii) development of post-COVID-19 (p<0.0001) and (iv) increased risk of a larger post-COVID-19 burden of disease.
Conclusions: We found a statistically significant association between CVR, severity of COVID-19, and post-COVID-19 syndrome three months after the end of acute disease.